The FDA warned Corcept Therapeutics that it would face significant hurdles if it submitted its lead rare disease asset for ...
Zacks Investment Research on MSN
FDA accepts SMMT's application seeking approval for NSCLC drug
Summit Therapeutics SMMT announced that the FDA has accepted its biologics license application (BLA) seeking approval for ...
A new drug application (NDA) has been submitted to the FDA seeking approval of lirafugratinib (RLY-4008), a selective FGFR2 ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
GlobalData on MSN
Life Bio receives FDA approval for ER-100 clinical trial
The Phase I trial will recruit participants who have been diagnosed with non-arteritic anterior ischaemic optic neuropathy and open-angle glaucoma.
GlobalData on MSN
RevBio receives FDA clearance for cranial bone glue trial
The FDA has authorised up to 15 clinical sites to take part in the study.
The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
Clene is scheduled to meet with the FDA in the coming months to discuss new data for CNM-Au8, its experimental oral therapy for ALS.
Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in patients with glaucoma and NAION.
Even as Johnson & Johnson’s oncology superstar Darzalex Faspro racks up megablockbuster sales and reshapes the multiple ...
FDA approves KBroVet chewable tablets for managing canine idiopathic epilepsy.
8don MSN
Pro-life organization calls on HHS and FDA to suspend abortion pill approval, tighten safety rules
Live Action alleges "reckless distribution" of the abortion drug mifepristone, urging the Trump administration to suspend its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results